Spilled Hazardous Drugs: The need of an Inactivation Method

American Society of Hospital Pharmacists. ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs. Am J Hosp Pharm 1990; 47: 1033–49.

Van Raalte J Rice C Moss CE . Visible-light system for detecting doxorubicin contamination on skin and surfaces. Am J Hosp Pharm 1990; 47: 1067–74.

Castegnaro M Adams J Armour MA Barek J Benvenuto J Confalonieri C , eds, Laboratory decontamination and destruction of carcinogens in laboratory wastes: some antineoplastic agents. Lyon: WHO/International Agency for Research in Cancer. IARC Scientific Publication 73, 1985.

Monteith DK Connor TH Benvenuto JA Fairchild EJ . Theiss Je. Stability and inactivation of mutagenic drugs and their metabolites in the urine of patients administered antineoplastic therapy. Environ Mol Mutagen 1987; 10: 341–56.

Lunn G Sansone EB Andrews AW Hellwig LC . Degradation and disposal of some antineoplastic drugs. J Pharm Sci 1989; 78: 652–9.

Johnson EG Janosik JE . Manufacturers' recommendations for handling spilled antineoplastic agents. Am J Hosp Pharm 1989; 46: 318–9.

Dorr RT Alberts DS . Topical absorption and inactivation of cytotoxic anticancer agents in vitro. Cancer 1992; 70 (suppl 4): 983–7.

Benvenuto JA Connor TH Monteith DK Laidlaw JL Adams SC Matney TS Degradation and inactivation of antitumor drugs. J Pharm Sci 1993; 82: 988–91.

McDiarmid MA Gurley HT Arrington D . Pharmaceuticals as hospital hazards: managing the risks. J Occup Med 1991; 33: 155–8.